Current Role for Chemoimmunotherapy in CLL

John Burke, MD, comments on whether there is still rationale to use CD20-targeted therapy with chemotherapy in patients with chronic lymphocytic leukemia, other than FCR in younger, fit patients. Website: https://www.onclive.com Twitter:   / onclive   Facebook:   / onclive   LinkedIn:   / onclive